StreetAlpha.app
Home › Stocks › FRNM

Freenome, Inc. (FRNM)

Members
LATEST PRICE

Freenome is a blank check company seeking to combine with a healthcare, life sciences or medical technology business. FRNM reports earnings on Tue, Nov 10, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 5 firms (5 buy, 0 hold, 0 sell).

Prices, price targets and earnings estimates for FRNM are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is FRNM in one of our four AI portfolios? Sign in free to see
See how it works→ Details ↓

Earnings

Earnings calendar →
Next report
Nov 10
2026 · Time not announced
Consensus EPS forecast
Members
EPS and revenue estimates
Year-ago EPS
Members
Same quarter last year
Options-implied move
Members
Move priced in by options
Analyst consensus
Strong Buy
Based on 5 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
5firms
5 Buy0 Hold0 Sell
Each firm's latest rating on FRNM in the past 90 days
Average 12-month target
Price targets for FRNMThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
GuggenheimInitiated
Aug 20Buy
TD CowenInitiated
Aug 18Buy
JefferiesInitiated
Aug 17Buy
BTIGInitiated
Aug 17Buy
Leerink PartnersInitiated
Aug 14Buy
DateFirmActionRatingPrice target
Aug 20GuggenheimInitiatedBuy
Aug 18TD CowenInitiatedBuy
Aug 17JefferiesInitiatedBuy
Aug 17BTIGInitiatedBuy
Aug 14Leerink PartnersInitiatedBuy
Loading…

Whale Options Flow

90D

No whale options trades in FRNM in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FRNM is in one of them and how their past FRNM trades turned out.

See how it works→ View all auto pilots→
FRNM in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FRNM in an article yet. Here's the latest on the wider market.

macronewsFriday, October 30, 2026
Binance and Polymarket Hacks Test Crypto's Plumbing, Not Yet Macro
Binance paused withdrawals after a suspected theft of roughly $6 billion, while Polymarket halted trading for an hour after a vendor breach.
Jean Westart · 3 min read
macronewsMonday, October 26, 2026
S&P 500 Sits 2.5% Below Its Record Ahead of the Fed and Big Tech
The S&P 500 slipped 0.47% to 7,623.68, 2.5% below its record, as the Fed meets October 28 and Alphabet, Microsoft and Amazon report.
Marie Crown · 3 min read
macronewsMonday, October 26, 2026
Hightower's Stephanie Link Tells Investors to Add on Volatility
Hightower's Stephanie Link told CNBC's Squawk Box that investors should use market volatility to add to portfolios as earnings season unfolds.
Adam Landser · 2 min read

About Freenome

Freenome is a blank check company, a shell formed to acquire or combine with an operating business. It has no operating revenue yet and is focused on healthcare, especially life sciences and medical technology companies in North America or Europe. The company has entered into an agreement for a business combination with Freenome Holdings, Inc., which is subject to closing conditions. Freenome is based in Brisbane, California.

Headquarters
Brisbane, CA
Summary based on the company’s 2026 annual report (10-K) ↗